Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities (2020 - 2025)
Ginkgo Bioworks Holdings (DNA) has disclosed Cash from Investing Activities for 4 consecutive years, with -$46.7 million as the latest value for Q4 2023.
- For the quarter ending Q4 2023, Cash from Investing Activities fell 256.94% year-over-year to -$46.7 million, compared with a TTM value of -$80.7 million through Dec 2023, down 19.73%, and an annual FY2025 reading of -$240.3 million, down 286.09% over the prior year.
- Cash from Investing Activities was -$46.7 million for Q4 2023 at Ginkgo Bioworks Holdings, down from -$3.4 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $29.7 million in Q4 2022 and bottomed at -$46.7 million in Q4 2023.
- Average Cash from Investing Activities over 4 years is -$19.2 million, with a median of -$23.0 million recorded in 2021.
- The sharpest move saw Cash from Investing Activities soared 603.41% in 2022, then plummeted 256.94% in 2023.
- Year by year, Cash from Investing Activities stood at -$28.8 million in 2020, then skyrocketed by 114.67% to $4.2 million in 2021, then skyrocketed by 603.41% to $29.7 million in 2022, then tumbled by 256.94% to -$46.7 million in 2023.
- Business Quant data shows Cash from Investing Activities for DNA at -$46.7 million in Q4 2023, -$3.4 million in Q3 2023, and -$11.2 million in Q2 2023.